| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 03/01/2011 | US7897618 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 03/01/2011 | US7897613 Crystalline polymorphs of clopidogrel |
| 03/01/2011 | US7897590 Methods to mobilize progenitor/stem cells |
| 03/01/2011 | US7897384 Chondrocyte therapeutic delivery system |
| 03/01/2011 | US7897180 Enamel matrix protein composition for treatment of systemic inflammatory response |
| 03/01/2011 | CA2437240C Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof |
| 03/01/2011 | CA2339331C Expression and export of angiogenesis inhibitors as immunofusins |
| 02/24/2011 | WO2011021678A1 Fused heterocyclic compound |
| 02/24/2011 | WO2011020886A1 Novel quinoline-hepcidine antagonists |
| 02/24/2011 | WO2011020866A2 Albumin fused coagulation factors for non-intravenous administration in the therapy and prophylactic treatment of bleeding disorders |
| 02/24/2011 | WO2010137855A9 Multi-layer tablet comprising effervescent layer |
| 02/24/2011 | WO2010007502A8 Platelet fraction deriving from placental blood |
| 02/24/2011 | US20110046606 Catheter injectable depot compositions and uses thereof |
| 02/24/2011 | US20110046183 Crystal of benzimidazole compound |
| 02/24/2011 | US20110046136 Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associcated therewith |
| 02/24/2011 | US20110046132 Benzoimidazoles as prolyl hydroxylase inhibitors |
| 02/24/2011 | US20110046109 2,4,8-trisubstituted-8h-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy |
| 02/24/2011 | US20110046061 Coagulation factor VII compositions and methods of making and using same |
| 02/24/2011 | US20110046060 Coagulation factor IX compositions and methods of making and using same |
| 02/24/2011 | US20110046059 Pharmaceutically acceptable formulations/compositions for peptidyl drugs |
| 02/24/2011 | US20110045589 Methods Of Controlling Proliferation And Differentiation Of Stem And Progenitor Cells |
| 02/24/2011 | US20110045569 Enzymatic conversion of blood group a, b, and ab red blood cells using alpha-n- acetylgalactosaminidases and alpha-galactosidases with unique substrate specificities and kinetic properties |
| 02/24/2011 | US20110045481 Methods and compositions for the assessment of drug response |
| 02/24/2011 | US20110045097 Solid pharmaceutical composition comprising irbesartan |
| 02/24/2011 | US20110045054 Materials and methods for treating and managing plaque disease |
| 02/24/2011 | US20110045034 Gelatin Sponge Comprising an Active Ingredient, Its Preparation and Use |
| 02/24/2011 | US20110045028 Sustained release preparation |
| 02/24/2011 | US20110045008 Therapeutic agents for inducing platelet fragmentation and treating thromboembolic disorders |
| 02/24/2011 | US20110045007 Fusion or linked proteins with extended half life |
| 02/24/2011 | US20110044974 Peptide analogues comprising at least one type of aminoacylaza-$g(b)<sp>3</sp>and the use thereof, in particular for therapy |
| 02/24/2011 | US20110044971 Method and composition for treating a seratonin receptor-mediated condition |
| 02/24/2011 | US20110044941 Immunotherapy for reversing immune suppression |
| 02/24/2011 | US20110044905 Oxytocin analogues |
| 02/24/2011 | US20110044903 Methods for producing microbubbles |
| 02/24/2011 | CA2770762A1 Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder therapeutics |
| 02/24/2011 | CA2770609A1 Albumin fused coagulation factors for non-intravenous administration in the therapy and prophylactic treatment of bleeding disorders |
| 02/23/2011 | EP2287285A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 02/23/2011 | EP2286848A2 Local vascular delivery of mycophenolic acid in combination with rapamycin to prevent restenosis |
| 02/23/2011 | EP2285812A1 HYDROGENSULFATE SALT OF 2-ACETOXY-5-(a-CYCLOPROPYLCARBONYL-2-FLUOROBENZYL)-4,5,6,7-TETRAHYDROTHIENO[3,2-c]PYRIDINE AND ITS PREPARATION |
| 02/23/2011 | EP2285412A1 Formulations of peg-functionalised serine proteases with high concentrations of an aromatic preservative |
| 02/23/2011 | EP2285400A2 Treatment of bleeding with low half-life fibrinogen |
| 02/23/2011 | EP2285375A2 Spiroazaindoles |
| 02/23/2011 | EP1954696B1 2-phenoxy-n-(1,3,4-thiadizol-2-yl)pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders |
| 02/23/2011 | EP1524998B1 Stable aqueous pharmaceutical composition comprising erythropoietin |
| 02/23/2011 | EP1448550B1 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with tnf activity |
| 02/23/2011 | CN1934252B Thrombin derivatives and medicinal composition containing the same |
| 02/23/2011 | CN101981035A Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments |
| 02/23/2011 | CN101981034A Triazolopyridazines as PAR1 inhibitors, production thereof, and use as medicaments |
| 02/23/2011 | CN101981027A Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses |
| 02/23/2011 | CN101981006A Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals |
| 02/23/2011 | CN101980710A Imidazopyridazines as PAR1 inhibitors, production thereof, and use as medicaments |
| 02/23/2011 | CN101979581A S7 gene and coded recombinant protein of grass carp reovirus strain, and acquisition method and application thereof |
| 02/23/2011 | CN101979412A IL-18 binding proteins |
| 02/23/2011 | CN101979409A Scorpion venom polypeptide for promoting cell proliferation, preparation method and medicinal application thereof |
| 02/23/2011 | CN101979057A Medicine for treating anaphylactoid purpura and preparation method thereof |
| 02/23/2011 | CN101979010A Chinese medicament for treating metrorrhagia |
| 02/23/2011 | CN101978976A Method for extracting and purifying total phenolic acid from fresh ramie leaves |
| 02/23/2011 | CN101978966A Preparation process of H1N1 influenza virus inactivated antibody plasma for treating and producing raw material |
| 02/23/2011 | CN101978951A 9,10-diphenylanthracene(DPA) ester fat emulsion intravenous injection and manufacturing method thereof |
| 02/22/2011 | US7893204 Attractin/mahogany-like polypeptides |
| 02/22/2011 | US7893090 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 02/22/2011 | US7893071 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic |
| 02/22/2011 | US7893036 In vivo production of small interfering RNAs that mediate gene silencing |
| 02/22/2011 | US7892578 Treatment of hematologic disorders |
| 02/22/2011 | CA2486378C Preparation and application of total salvianolic acid |
| 02/22/2011 | CA2472093C Use of sulfated glycosaminoglycans for establishing effective labor in women |
| 02/22/2011 | CA2470575C Spiroazacyclic compounds as monoamine receptor modulators |
| 02/22/2011 | CA2447712C Herbal drug composition for cartilage protection |
| 02/22/2011 | CA2441566C Blood cell production via activation of the hemoglobin scavenger receptor |
| 02/22/2011 | CA2319198C Substituted oxoazaheterocyclyl factor xa inhibitors |
| 02/17/2011 | WO2011020045A1 Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels |
| 02/17/2011 | WO2011019990A1 Use of e5501 for stimulating platelet production |
| 02/17/2011 | WO2011019023A1 Agent for ameliorating blood-brain barrier disorders |
| 02/17/2011 | WO2011018588A2 Fgf receptor-activating n-acyl octasaccharides, preparation thereof, and therapeutic use thereof |
| 02/17/2011 | WO2011018587A2 Fgf receptor-activating n-sulfate oligosaccharides, preparation thereof, and therapeutic use thereof |
| 02/17/2011 | WO2011018582A2 Floating microgranules |
| 02/17/2011 | WO2011018515A1 Method of purifying pegylated proteins |
| 02/17/2011 | WO2010123845A3 Siderophore conjugate immunogenic compositions and vaccines |
| 02/17/2011 | US20110039895 Prolyl hydroxylase inhibitors |
| 02/17/2011 | US20110039886 Enhanced erythropoiesis and iron metabolism |
| 02/17/2011 | US20110039862 Protease Inhibitors |
| 02/17/2011 | US20110039828 Tetrahydroquinoline derivatives and a process for preparing the same |
| 02/17/2011 | US20110039780 Platelet glycoprotein ib alpha variant fusion polypeptides and methods of use thereof |
| 02/17/2011 | US20110038950 Enhanced erythropoiesis and iron metabolism |
| 02/17/2011 | US20110038943 Milkweed seed oil administered to animals |
| 02/17/2011 | US20110038936 System and method for electrospun drug loaded biodegradable chemotherapy applications |
| 02/17/2011 | US20110038925 Intravenous formulations of neurokinin-1 antagonists |
| 02/17/2011 | US20110038874 Anti-vegfr monoclonal antibody, method of making and uses thereof |
| 02/17/2011 | US20110038838 Probiotic enhancement of steroid and immune suppressor activity in mammals with chronic diseases |
| 02/17/2011 | US20110038836 Device and Method for Transfecting Cells for Therapeutic Use |
| 02/17/2011 | US20110038831 Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels |
| 02/17/2011 | CA2771056A1 Fgf receptor-activating n-acyl octasaccharides, preparation thereof, and therapeutic use thereof |
| 02/17/2011 | CA2771055A1 Fgf receptor-activating n-sulfate oligosaccharides, preparation thereof, and therapeutic use thereof |
| 02/17/2011 | CA2771053A1 Floating microgranules |
| 02/17/2011 | CA2770822A1 Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels |
| 02/16/2011 | EP2284189A2 Nucleic acid molecules encoding fibroblast growth factor-like (FGF-like) polypeptides |
| 02/16/2011 | EP2284187A2 Process for the purification of antithrombin-III |
| 02/16/2011 | EP2284159A1 5-hydroxypyrimidine-4-carboxamide compound |
| 02/16/2011 | EP2284149A1 Selective androgen receptor modulators and methods of use thereof |
| 02/16/2011 | EP2283869A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in the treatment of viral infections and cancer |